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Abstract 
Background: Chronic high blood pressure has for many years 
been considered a public health problem. Eugenia punicifolia is a 
plant used to treat diabetes by the local population, however its 
hypotensive effect has never been investigated. 
Materials and methods:The effect of the 21-day treatment on 
systolic blood pressure was measured using the two kidneys, one clip 
(2K1C) model with hypertensive Goldblatt rats, which were treated 
with a repeated dose of 0.30 g/kg/day of extract by gavage (EEP group 
300) and 0.15 g/kg/day (EEP group 150). Prior to pharmacological 
testing, acute toxicity tests were also performed on the rats. The activity 
of plasma angiotensin converting enzyme (ACE) during the experiment 
was determined spectrofluorometrically.  
Results: The EEP, in concentrated form, inhibited ACE 
activity  and a hypotensive effect in vivo. Systolic blood pressure (SBP) 
levels were significantly reduced  in the EEP 150 and EEP 300 groups, 
respectively. ACE activity was inhibited in plasma.  
Conclusion: Eugenia punicifolia appears to affect blood 
pressure significantly. Hypotension produced by the EEP extract can 
be related to the inhibition of ACE.  
 
Keywords: Angiotensin converting enzyme; Hypotension; Eugenia 
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BACKGROUND 
Foods rich in sodium consumed without due control collaborate to 
increases in blood pressure and aggravate hypertension [1, 2]. 
Statistics suggest that, by 2025, 56 billion individuals will suffer from 
hypertension [2].  One of the particularities of hypertension is the 
action of the renin-angiotensin system, in the vasomotor center, which 
is responsible for the relaxation or constriction of blood vessels. This 
modulation process occurs because renin converts the angiotensinogen 
to angiotensin I. [3].  
Angiotensin I is converted to angiotensin II, a powerful 
vasoconstrictor intermediated by the angiotensin-converting enzyme 
(ACE) [4]. This process causes, among other implications, 
inflammation of the blood vessels, autonomic alterations of the 
myocardium, and also reduction in the salt and water eliminated by 
the kidneys [6, 7, 8, 9]. Consequently, blood pressure is raised [10].  
The literature relates the use of several plant extracts that 
have antihypertensive effects in humans and animals.  Quedrago et 
al. (2011) [11] demonstrate the use of 0.01-10 mg/ml Agelanthus 
dodoneifolius in monortense rats. Similarly, González-Peña et al. 
(2014) [12] used 10% onion powder (Allium cepa) mixed with a diet 
supplemented with cholesterol.  At the end of the studies, the 
researchers observed decreases in blood pressure in the supplemented 
groups when compared to the control group.  
For hypertensive humans, Ashraf et al. (2013) [13] prescribed 
garlic capsules (Allium Sativum L) containing 300-1500 mg/day for 24 
weeks.  The study showed significant a decrease in both systolic and 
diastolic blood pressure in both dose and duration dependent manner.  
In other studies, the inhibitory effects on ACE using plant extracts 
have been investigated [14, 15, 16].  
The species Eugenia punicifolia, which belongs to the 
Myrtaceae family and is known by the natives of the Amazon as the 
"insulin plant" [17, 18].  
Previous studies have shown that this species presents anti-
inflammatory effects [19], as well as antioxidant [18, 20], antidiabetic 
[21], gastroprotective [22], antibacterial [23] and antimicrobial effects 
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[24]. These pharmacological properties are attributed to the high 
concentration of flavonoids and monoterpenes, and also the condensed 
tannins present in this plant [25, 26,].  
However, the literature does not report studies regarding the effects 
of this species on blood pressure.  Therefore, the aim of this study was 
to investigate the effects of E. punicifolia extract (EEP) on ACE 
inhibition in vitro and its hypotensive effect in vivo. 
 
MATERIALS AND METHODS 
 
This experimental study was conducted in the state of Amazonas as  
result of the thesis of PhD in Biotechnology at the Federal University 
of Amazonas.  It aimed to analyze biological activities in vitro and in 
vivo of the aqueous extract of the leaves of the E. punicipoly (EEP), 
emphasizing the inhibitory activity of digestive enzymes, enzyme 
angiotensin-converting (ACE), antioxidant, hypolipemiant, cytotoxic 
and antihypertensive effects 
 
Reagents 
The chemical compounds and the following reagents were used in this 
experiment: Quinic acid (PubChem CID: 6508); Chlorogenic acid 
(PubChem CID: 1794427); Gallic acid (PubChem CID: 370); 
Protocatechuic acid (PubChem CID: 72); Vanillic acid (PubChem CID: 
8468); Catechin (PubChem CID: 73160); Quercetin (PubChem CID: 
5280343). All remaining reagents were of the highest purity available 
(≥ 98%).  
 
Preparation of E. punicifolia extract (EEP) 
Dry E. punicifolia leaves were supplied by Embrapa-Amazonas 
Occidental. The extraction was performed using infusion for 15 
minutes in a proportion of 7.5% (w/v) inordance with Galeno et al. 
(2014)  [17]. The dry product was obtained by spray drying (Mini 
Spray Dryer/MSD 1.0, Labmaq, São Paulo, Brazil). 
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Bioassay procedure for ACE inhibition  
The EEP inhibition activity assay was adapted from Serra et al. 
(2005) [27]. The ACE solution was obtained from an extract of rabbit 
lung acetone (Sigma) at a concentration of 100 mg/mL in phosphate 
buffer (5 mM, pH: 8.0). 
The ACE inhibition assay was determined by inhibiting the release of 
the dipeptide L-leukin-L-histidine (His-Leu) formed in the hydrolysis 
of the synthetic tripeptide substrate Hippuryl-L-histidine L-leukin 
(Hip-His-Leu) (5 mM) by ACE. 
  The His-Leu of dipeptide formed was coupled to a fluorescent 
substance, orthophthaldialdehyde (2% in methanol; 10 mL) and the 
resulting fluorescence was quantified by the fluorimeter and read in 
the ELISA reader (DTX 800 Multimodal Detector, Beckman Coulter) 
The calculation of the inhibition percentage was as follows: % 
inhibition = 100 - (sample absorbance/control absorbance) X 100. 
 
Chemical composition analyses 
Liquid chromatography (LC-MS/MS, Shimadzu SPDM10) coupled to a 
Bruker Amazon-trap ion mass spectrometer was used. The 
electrospray (ESI) was used to explore the phenolic composition of E. 
punicifolia extract.  
Chromatographic separation was performed in a C18 column 
(Shimadzu, 5 μm, 250 x 4.6 mm) using a binary mobile phase. The 
temperature was maintained at 20 °C with an injection volume of 10 
μL. For structural elucidation, the MS/MS spectral data which were 
obtained were compared with data from previous literature [28, 29].   
 
Animals and ethical considerations 
Wistar rats (200-350 g) were kept under controlled conditions 
(temperature: 23±1 °C and light: 08:00h to 20:00h), and received food 
ad libitum. 
  The procedures were approved by the Ethics Committee at the 
Universidade Federal do Amazonas, (Approval No.CEEA-UFAM 
77/2012) and were conducted in accordance with the Declaration of 
Helsinki. 
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Evaluation of EEP acute toxicity  
After  2 hours of fasting, the animals (n = 12) were divided into two 
groups: Group 1 – animals that received  a single oral dose of EEP (2 
g/kg) and Group 2 –  control animals that received saline solution 
(0.9%), under the same experimental conditions.  
Subsequently, the rats were observed for 60 minutes in 
individual cages and during the first 48 h until the 14th day for any 
indication of toxic shock syndrome or mortality [30, 31]. At the end of 
the 14 days, the animals were anesthetized with ketamine and 
xylazine to obtain plasma and evaluate the biochemical parameters.  
 
Effects of EEP on blood pressure  
After anesthesia, the animals were submitted to a laparotomy in 
order to expose the renal peduncle. A small silver clip (2 x 5 cm) with 
0.2 mm was placed over the left renal artery. The control group was 
submitted to the same surgical procedure, but without partial 
occlusion of the renal artery.    
After surgery, 30 rats were randomly distributed into five 
groups: normotensive (2K or SHAM), hypertensive (2K1C), enalapril 
hypertensive (ENAL), hypertensive and receiving 150 mg/kg/day of 
extract (EEP150) and hypertensive and receiving 300 mg/kg/day 
extract (EEP 300), both orally.   
The effects of EEP on blood pressure (BP) were indirectly 
evaluated by tail-cuff plethysmography. BP was measured before and 
after surgery until the sixth week.  During the treatment period, the 
systolic blood pressure was measured three times a week. Animals 




The experimental treatment was started 21 days after the third week 
of continuous clamping of the renal artery or farse surgery.  
Treatment was via gavage with EEP (0.150 g/kg or 0.300 
g/kg), the vehicle  was saline (1 mL/kg) or enalapril (20 mg/kg).  The 
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At the end of the experiment, about 1 mL of blood was drawn via 
heart puncture from all rats of the 5 groups.  
The plasma was separated by centrifugation (10 min, 3000 
rpm, 10°C) and stored at 20 °C, until the time of determination of 
enzymatic activity and biochemical analysis.  
Analysis was performed using the automatic Cobas Mira® 
analyzer using BIOCLIN® kits. The animals were submitted to a 
previous fasting of 12 hours.  Relative fluorescence was determined in 
all groups for ACE activity [32]. 
 
Statistical analysis 
Data with a normal distribution were assessed using univariate 
analysis of variance (either one-way ANOVA or two-way ANOVA), 
followed by the Bonferroni or Tukey post-test. Data were expressed as 
mean ± SEM.    
In all cases, differences were considered significant when the 
p value was < 0.05. All analyses were performed with GraphPad 
Software, USA, for Windows 7.  In vitro results were presented as the 
means ± standard deviations of measurements in triplicate.  
The 50% inhibitory concentration (IC50) values were obtained 
by non-linear regressions of concentration–response curves using the 




In the present study, for the first time, the ACE inhibitory activity of 
Eugenia punicifolia extract was demonstrated. EEP (0.3 mg/mL) was 
able to inhibit 70.8% of enzyme activity. Captopril inhibited 83.6% at 
0.003 mg/m. 
As shown in Figure 1A, EEP inhibited ACE activity in a 
concentration-dependent manner showing an IC50 value of 24.3 ± 0.7 
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µg/mL, while captopril has an IC50 value of 0.9 ± 0.1 µg/mL (Figure 
1B).  
In an attempt to identify biologically active compounds related 
to ACE inhibition activity, the phenolic composition of EEP was 
analyzed by LC-MS/MS (Figure 2).  
The fragments found were compared with fragmentation 
previously described in the literature [17, 29]. The phenolic 
compounds in Figure 2 have been previously reported and the 
fragment data belong to the large class of phenolic compounds (Table 
1) 
Before starting the evaluation of biological activities of EEP, 
acute toxicity tests were performed in vivo, using EEP at a dose of 2 
g/kg.  
  No neurotoxic effects were observed in the groups treated with 
EEP, when compared to the control group.  Subsequently, the effects 
of EEP and enalapril on blood pressure were evaluated in the 
hypertensive animals for 21 days after the establishment of 
hypertension, as can be seen in Figure 3. 
Systolic blood pressure (SBP) was evaluated for six weeks. 
Hypertensive rats were treated with two different doses of EEP (150 
mg/kg/day and 300 mg/kg/day), or enalapril (20 mg/kg/day), after 
confirmation of hypertension (3rd week).  
For the EEP 150 group, SBP values decreased from 215.4 ± 
2.6 mmHg to 168.7 ± 0.3 mmHg (a reduction of 21.7%). Additionally, 
when compared to untreated hypertensive rats (2K1C), the EEP 150 
group presented a significant drop in SBP only after 5 weeks of 
treatment (p < 0.001).  
Moreover, the observed drop in SBP did not reach the values 
observed in normotensive animals (2K), which were treated with 
saline solution (0.9 %). 
In the EEP 300 group, SBP values decreased from 173.1 ± 3.3 
mmHg to 144.0 ± 1.3 mmHg (16.8 %), resulting in significantly lower 
SBP values when compared to the 2K1C group between the fourth 
and sixth weeks of treatment ( p <0.001).  
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In the enalapril group (20 mg/kg/day), SBP decreased from 
202.2 ± 0.7 mmHg to 146.4 ± 3.2 mmHg ( 38.1%), compared to the 
2K1C group in the 4th week of treatment (p <0.001). Finally, the EEP 
150 group showed a hypotensive effect similar to the enalapril group 
in the sixth week of treatment (p > 0.05). 
As show in Figure 4, ACE activity was measured in all the 
experimental groups. The quantification of ACE in the EEP 300 group 
did not differ from the normotensive group (2K) (p > 0.05), though it 
was statistically different from the hypertensive group (2K1C) (p < 
0.05).  
From these results, we can infer that the inhibition of ACE 
was a result of EEP treatment, since the enzymatic levels were high 
in the untreated hypertensive animals. The activity of ACE in the 
enalapril group was similar to that of the hypertensive group (2K1C). 
At the end of the experiments, biochemical parameters were 
also evaluated (Table 2). The total cholesterol (C) values were lower in 
both of the EEP treatments (150/300), as well as in the enalapril 
group (p <0.001). 
Moreover, the samples from the EEP 300 group showed a 
greater reduction (48%), when compared to the samples from the EEP 
150 group (37.95%), as well as those from the enalapril group (42.9%).  
Triglycerides (TG) and VLDL-cholesterol values were also 
reduced during treatment, and the EEP at the highest dose was able 
to reduce these levels by approximately 52% (p <0.001) compared to 
the enalapril group 40% (p <0.01).  
In relation to HDL-c, the LDL-c values increased by 161.8% 
after hypertension induction (p <0.01 vs. normal blood pressure) and 
were reduced by 55.7%, 39 4% and 51.4% after EEP300, EEP150 and 
enalapril administration, respectively. The EEP did not alter the 
blood glucose levels, and the values were within the normal range 
[32].   
The anthropometric measurements did not change 
significantly between the groups. However, weight gain was less 
pronounced in the EEP 150 (9%) and EEP 300 (6%) groups when 
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Figure 1. Angiotensin converting enzyme (ACE) inhibitory activity of E. 
punicifolia extract (A) and captopril (B). Data were expressed as IC50 (mean ± 
standard deviation of triplicate values). The E. punicifolia concentrations 
(EEP)/captopril were diluted according to the final volume of the microplate 
well. 
 
Figure 2. Representative chromatogram (LC-MS/MS) obtained from EEP 
extract showing the following compounds: (1) quinic acid, (2) chlorogenic 
acid, (3) gallic acid, (4) protocatechuic acid, (5) vanillic acid, (6) catechin, and 
(7) quercetin. 
 
Figure 3. Evolution of systolic blood pressure (SBP) between groups. Data 
were expressed as mean ± standard error of the mean (n = 5-7). Multiple 
comparisons were done by two-way ANOVA followed by the Bonferonni post-
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test vs. Hypertensive group (2K1C) *** (p <0.001). Normotensive group (2K); 
Hypertensive group (2K1C); Group hypertension Enalapril 20 mg/kg/day 
(ENAL); Group hypertensive extract 150 mg/kg/day (EEP150) and Group 
hypertensive extract 300 mg/kg/day (EEP300). 
Table 1. Phenolic compounds  identified by LC-MS/MS 
RT(min), retention time; (m/z, [M-H]-) deprotonated molecule (m/z, [M-H]-); MS/MS, 
fragments. 
Table 2. Biochemical variables among hypertensive and normotensive groups 
CT, total cholesterol; TG, triglycerides; HDL-c, high-density lipoprotein cholesterol 
ratio;  LDL-c, low-density lipoprotein cholesterol; GL, Glucose; VLDL-c, very low-
density lipoprotein cholesterol. Different letters mean that there were significant 
differences between the groups (p <0.05) and identical letters indicated there were no 
significant differences (p> 0.05). 
 
 
Figure 4. Relative Fluorescence values between groups. Data were expressed 
as mean ± standard deviation (n = 3-7). Multiple comparisons were made by 
two-way ANOVA followed by Tukey post-test. Different letters mean that 
there were significant differences between the groups (p <0.05) and identical 
letters indicated there were no significant differences (p> 0.05). 
Peak Rt (min) m/z, [M-H]- Fragment ions identification 
1 8.89 191 127, 109, 93 Quinic acid 
2 9.22 353 191 Chlorogenic acid 
3 11.09 169 125 Gallic acid 
4 11.80 153 109 Protocatechuic acid 
5 12.05 167 139, 111 Vanillic acid 
6 12.46 289 191, 189 Catechin 
7 12.94 301 179, 151 Quercetin 
Variables 2K 2K1C EEP150 EEP300 ENAL 
CT (mg/dL) 59,2 ±3,5a 119,2 ± 16,4 b 74 ± 13,3 a 61 ± 6,8 a 68 ± 8,7 a 
TG (mg/dL) 43,2 ± 5,6 a 63,5 ± 8,0 b 52,5 ± 13,0 a,b 30 ± 10,4 a 38,0 ± 10,1 a 
VLDLc (mg/dL) 8,6 ± 1,1 a 12,7 ± 1,8 b 11,9 ± 1,4 a,b 6,1 ± 2,0 a 7,6 ± 2,0 a 
HDLc (mg/dL) 26,8 ± 3,4 a 28,8 ± 2,0 a 31,8 ± 4,7 a 28,3 ± 2,6 a 30,4 ±4,0 a 
LDLc (mg/dL) 24,9 ± 1,3 a 65,2 ± 20,7 b 39,5 ± 6,9 a 28,9 ± 8,9 a 31, 7 ± 4,2 a 
GL (mg/dL) 111,3 ± 21,2 a 94,5 ± 10,6 a 90,3 ± 7,4 a 99,4 ± 15,0 a 63,5 ± 9,6 b 
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DISCUSSION 
             
Studies have shown that plant extracts, such as Tribulus terrestris 
[33], Phyllanthus urinaria [34], Egyptian Tropaeolum majus L. [35] 
and Moringa oleifera Lam. (Moringaceae) [36], are potent ACE 
inhibitors. In this study, the inhibitory action of Eugenia punicifolia  
extract (EEP) in a concentration-dependent manner (IC50 24.3 ± 0.7 
µg/mL) was also evidenced in vitro when compared to captopril as a 
control.   
           This is an important discovery and, as far as we know, it is the 
first time that an extract of the Myrtaceae family has been shown to 
inhibit this enzyme. This inhibition may have occurred due to the 
high concentrations of phenolic compounds found in the EEP extract 
(Table 1).  
The phenolic compounds interact with bradykinin-mediated 
nitric oxide and characterize the hypotensive effects [37]. These 
effects lead to an increase in renal blood flow and diminish the 
vascular resistance caused by the blockage of the calcium inflow, 
which leads to a reduction in cardiac output [38, 39].   
            Additionally, the literature describes several compounds 
derived from plants which have the capacity to inhibit the activity of 
ACE in vitro, such as proanthocyanidins, tannins, peptides, 
xanthones, terperoids, and quercetin [40, 41, 42, 43]. Quercetin 
together with quinic acid, chlorogenic acid, gallic acid were identified 
in this study (Figure 2) and are among those cited in the literature for 
their anti-hypertensive action [44, 45, 46].  
             Studies have demonstrated the action of quercetin on ACE 
and its reduction of the pressure effect of angiotensin I, similar to the 
effect of captopril [47] Quercetin exerts an antioxidant effect on 
endothelial dysfunction, improving vascular function. Synergic effects 
of acids, such as quinic acid, chlorogenic acid, gallic acids may have 
contributed to the ACE inhibition result found in this study [48, 49]. 
             The present study demonstrated that supplementation of EEP 
150 mg/kg/day and EEP 300 mg/kg/day led to a decrease in blood 
pressure.  
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Furthermore, evidence indicates a positive association between the 
ingestion of diets rich in phenolic compounds and the control of 
platelet aggregation, in the reduction in the oxidation of LDLc, and 
greater release of nitric oxide from the endothelium [50].  
             Chen et al.  [51] describe a vasorelaxant effect in a compound 
that is also found in the EEP extract. These effects help in 
myocardium perfusion [52].  
Moreover, in this study, it has been shown for the first time 
that EEP has a hypotensive effect in vivo (Figure 4). Similar results 
found by Suveren et al. [53], while testing an extract from Viscum 
album L., confirmed once again the hypotensive potential of EEP, as 
found in our research.  
              Similarly, Zhou et al. [54] used an ethanolic extract from 
Cydonia oblonga in normotensive rats, and confirmed an enzymatic 
inhibition (ACE) of 50%, soon after the administration of the extract, 
which reached its peak (120 %) after 1 hour.  
This effect was shown to be prolonged after 12 hours of 
treatment. Another beneficial effect found in the study by Zhou et al. 
[54]  was the hypocholesterolemic action of this extract.   
               Some authors consider that ACE inhibitors have the effect of 
significantly reducing lipid profile markers [55,56]. Ramalingam et al. 
[57] point out that ACE inhibitors can act on gene expression in 
adipocytes by increasing the adiponectin profile, leading to an 
increase in HDLc and reducing the plasma levels of triglycerides.  
             Considering that the hypotensive effect of EEP observed in 
this study was induced in rats through the installation of 
renovascular hypertension, it is recommended that new studies 
involving other models of hypertension be performed in order to 




In vitro, the E. punicifolia extract showed angiotensin-converting 
enzyme (ACE) inhibition activity. In vivo, the oral treatment using E. 
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punicifolia extract caused hypolipidemic and hypotensive effects in 
renal hypertensive rats.  
 Since this is the first study to test E. punicifolia extract in the 
inhibition of ACE, the results presented here corroborate the popular 
use of E. punicifolia, which can be a prominent ally in the treatment 
of hypertension and cardiovascular diseases, mainly due to the 
presence of antioxidant compounds, such as gallic acid, catechins, 
chlorogenic acid and quercetin.  
 
Abbreviations.  
(ACE):  angiotensin converting enzyme; (SBP):  systolic blood pressure; (HIS-LEU): 
dipeptide L-leukin-L-histidine; (MSD): mini spray dryer; (HIP-HIS-LEU):  hippuryl-L-
histidine L-leukin; (LC-MS/MS): liquid chromatography-MS/MS; (ESI):  electrospray; 
(BP): blood pressure; (IC50): the 50% inhibitory concentration;  (EEP): Eugenia 
punicifolia extract; (VLDL-c): very low-density lipoprotein cholesterol; (HDL-c): high-
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